Q3 2024 Holdings
Filed 2024-11-14 | 35 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $218.0M | 8,707,165 | 14.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $186.6M | 4,114,283 | 12.4% |
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $148.8M | 3,507,164 | 9.9% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $137.5M | 71,254,677 | 9.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $134.1M | 1,073,500 | 8.9% |
| Illumina Inc(ILMN) | COM | 452327109 | $97.8M | 750,000 | 6.5% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $95.8M | 2,084,841 | 6.4% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $65.5M | 9,251,108 | 4.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $46.8M | 170,000 | 3.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $44.3M | 650,000 | 3.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $41.1M | 2,000,000 | 2.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $30.7M | 700,000 | 2.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $30.2M | 326,378 | 2.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $28.8M | 990,000 | 1.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $24.9M | 8,100,000 | 1.7% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $22.7M | 666,308 | 1.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $22.0M | 524,616 | 1.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $19.3M | 3,995,571 | 1.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $19.0M | 775,000 | 1.3% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $13.0M | 6,732,971 | 0.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $12.4M | 1,150,000 | 0.8% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $9.4M | 2,000,000 | 0.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $9.2M | 1,188,349 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.1M | 475,000 | 0.6% |
| Guardant Health Inc(GH) | COM | 40131M109 | $8.0M | 350,000 | 0.5% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $5.7M | 296,666 | 0.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $5.5M | 3,212,316 | 0.4% |
| Grail Inc(GRAL) | COM | 384747101 | $4.8M | 350,000 | 0.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $3.7M | 973,260 | 0.2% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.8M | 1,035,859 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $1.4M | 367,175 | 0.1% |
| Exscientia PLC | ADS | 30223G102 | $1.0M | 213,900 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $455.9K | 86,014 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $297.4K | 36,493 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $123.8K | 123,839 | 0.0% |